Clinical Trial Update: Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of the Doxasozin GITS framework in patients with prostate enlargement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Doxasozin Gastrointestinal Therapeutic System (GITS) (Doxasozin Gastrointestinal Therapeutic System)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Prostate | Phase 4 | Status: COMPLETED